MEDAGLINI, DONATA
 Distribuzione geografica
Continente #
NA - Nord America 1.473
EU - Europa 744
AS - Asia 169
AF - Africa 20
SA - Sud America 19
Continente sconosciuto - Info sul continente non disponibili 4
OC - Oceania 4
Totale 2.433
Nazione #
US - Stati Uniti d'America 1.445
IT - Italia 256
IE - Irlanda 168
VN - Vietnam 71
DE - Germania 68
FR - Francia 63
GB - Regno Unito 35
CN - Cina 31
SE - Svezia 30
CA - Canada 27
IN - India 22
NL - Olanda 22
RU - Federazione Russa 20
CZ - Repubblica Ceca 17
ES - Italia 17
UA - Ucraina 14
ZA - Sudafrica 10
BR - Brasile 9
AE - Emirati Arabi Uniti 8
TH - Thailandia 8
FI - Finlandia 7
JP - Giappone 7
CH - Svizzera 6
CL - Cile 5
AU - Australia 4
GR - Grecia 4
PL - Polonia 4
CO - Colombia 3
IR - Iran 3
RO - Romania 3
AP - ???statistics.table.value.countryCode.AP??? 2
EG - Egitto 2
ID - Indonesia 2
IM - Isola di Man 2
IQ - Iraq 2
PE - Perù 2
RW - Ruanda 2
SA - Arabia Saudita 2
SG - Singapore 2
TW - Taiwan 2
ZW - Zimbabwe 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AT - Austria 1
BD - Bangladesh 1
BG - Bulgaria 1
BY - Bielorussia 1
ET - Etiopia 1
EU - Europa 1
KH - Cambogia 1
KR - Corea 1
LB - Libano 1
LU - Lussemburgo 1
LV - Lettonia 1
MX - Messico 1
MY - Malesia 1
NG - Nigeria 1
NO - Norvegia 1
PH - Filippine 1
PK - Pakistan 1
PT - Portogallo 1
SC - Seychelles 1
SI - Slovenia 1
TR - Turchia 1
UG - Uganda 1
UZ - Uzbekistan 1
Totale 2.433
Città #
Fairfield 181
Dublin 154
Ashburn 125
Santa Cruz 122
Siena 121
Seattle 98
Woodbridge 85
Houston 67
Dong Ket 65
Buffalo 61
Cambridge 43
Wilmington 39
Ann Arbor 31
Stockholm 26
Chicago 22
Redmond 18
Southend 18
New York 15
Las Vegas 13
Clearwater 12
San Diego 12
Boardman 11
Council Bluffs 11
Rome 10
Shanghai 10
Milan 9
Ottawa 9
Florence 8
Lake Forest 8
Los Angeles 8
Muizenberg 8
Phoenix 8
Wuhan 8
Amsterdam 7
Milpitas 7
University Park 7
Bologna 6
San Francisco 6
Frankfurt am Main 5
Helsinki 5
Herndon 5
Provo 5
Vancouver 5
Wiesbaden 5
Zaragoza 5
Dallas 4
Henderson 4
Jersey City 4
Paris 4
Sunnyvale 4
Ahmedabad 3
Bogotá 3
Büdelsdorf 3
Giugliano In Campania 3
Lincoln 3
Nuremberg 3
Riva 3
Sydney 3
Tappahannock 3
Turin 3
Zurich 3
Alexandria 2
Arlington 2
Auburn 2
Bangkok 2
Barcelona 2
Bengaluru 2
Bergamo 2
Brooklyn 2
Clifton 2
Cranberry Township 2
Da Nang 2
Delhi 2
Denver 2
Duncan 2
Durham 2
Genoa 2
Guangzhou 2
Gurugram 2
Hamilton 2
Ho Chi Minh City 2
Iesi 2
Katwijk 2
Kigali 2
Lappeenranta 2
London 2
Manchester 2
Miami 2
Montignoso 2
Munich 2
New Kensington 2
New Orleans 2
North Bergen 2
Norwalk 2
Polska 2
Portland 2
Porto Alegre 2
Prato 2
Providence 2
Pune 2
Totale 1.635
Nome #
Vaccination in the elderly: The challenge of immune changes with aging, file e0feeaa8-0535-44d2-e053-6605fe0a8db0 302
Role of the microbiota in the modulation of vaccine immune responses, file e0feeaa8-32d8-44d2-e053-6605fe0a8db0 180
Heterologous Prime-Boost Combinations Highlight the Crucial Role of Adjuvant in Priming the Immune System, file e0feeaa7-1439-44d2-e053-6605fe0a8db0 163
Transcriptomics of the vaccine immune response: Priming with adjuvant modulates recall innate responses after boosting, file e0feeaa7-8c4c-44d2-e053-6605fe0a8db0 145
Optimized protocol for the detection of multifunctional epitope-specific CD4+ T cells combining MHC-II tetramer and intracellular cytokine staining technologies, file e0feeaa8-33da-44d2-e053-6605fe0a8db0 140
Vaginal immunization to elicit primary T-cell activation and dissemination., file e0feeaa5-1710-44d2-e053-6605fe0a8db0 130
Recombinant Haemagglutinin Derived From the Ciliated Protozoan Tetrahymena thermophila Is Protective Against Influenza Infection, file e0feeaa8-a21f-44d2-e053-6605fe0a8db0 110
Innate immunity against HIV: a priority target for HIV prevention research, file e0feeaa7-99ad-44d2-e053-6605fe0a8db0 108
Peptide-specific T helper cells identified by MHC class II tetramers differentiate into several subtypes upon immunization with CAF01 adjuvanted H56 tuberculosis vaccine formulation, file e0feeaa5-7fb9-44d2-e053-6605fe0a8db0 98
Shelter from the cytokine storm: pitfalls and prospects in the development of SARS-CoV-2 vaccines for an elderly population, file e0feeaa9-2f5b-44d2-e053-6605fe0a8db0 90
Human Transcriptomic Response to the VSV-Vectored Ebola Vaccine, file e0feeaa9-8c0a-44d2-e053-6605fe0a8db0 85
Short or Long Interval between Priming and Boosting: Does It Impact on the Vaccine Immunogenicity?, file e0feeaa9-ac78-44d2-e053-6605fe0a8db0 72
A stochastic model for CD4+ T cell proliferation and dissemination network in primary immune response, file e0feeaa9-00d3-44d2-e053-6605fe0a8db0 64
Characterization of the antigen-specific CD4+ T cell response induced by prime-boost strategies with CAF01 and CpG adjuvants administered by the intranasal and subcutaneous routes, file e0feeaa5-779d-44d2-e053-6605fe0a8db0 62
Long-term anti-bacterial immunity against systemic infection by Salmonella enterica serovar typhimurium elicited by a GMMA-based vaccine, file e0feeaaa-1d70-44d2-e053-6605fe0a8db0 62
Modulation of Primary Immune Response by Different Vaccine Adjuvants., file e0feeaa6-2577-44d2-e053-6605fe0a8db0 61
Editorial: Advanced Immunization Technologies for Next Generation Vaccines, file e0feeaa9-2f5e-44d2-e053-6605fe0a8db0 60
Innovation Partnership for a Roadmap on Vaccines in Europe (IPROVE): A vision for the vaccines of tomorrow, file e0feeaa9-f3e1-44d2-e053-6605fe0a8db0 57
Immunomonitoring of human responses to the rVSV-ZEBOV Ebola vaccine, file e0feeaa9-ac11-44d2-e053-6605fe0a8db0 56
CD4+ T Cell Priming as Biomarker to Study Immune Response to Preventive Vaccines, file e0feeaa9-ac19-44d2-e053-6605fe0a8db0 53
Immunogenicity of a bivalent adjuvanted glycoconjugate vaccine against Salmonella typhimurium and Salmonella Enteritidis, file e0feeaa9-c0f0-44d2-e053-6605fe0a8db0 50
Interferon-γ from Brain Leukocytes Enhances Meningitis by Type 4 Streptococcus pneumoniae, file e0feeaa5-d2d9-44d2-e053-6605fe0a8db0 46
Optimized protocol for the detection of multifunctional epitope-specific CD4+ T cells combining MHC-II tetramer and intracellular cytokine staining technologies, file e0feeaa8-41f1-44d2-e053-6605fe0a8db0 46
Human neutralizing antibodies to cold linear epitopes and subdomain 1 of the SARS-CoV-2 spike glycoprotein, file 5093f088-7874-4b34-bb61-7372bb9cd697 41
The third dose of mRNA SARS-CoV-2 vaccines enhances the spike-specific antibody and memory B cell response in myelofibrosis patients, file fd3a4a73-9a65-4663-bcf3-55ba299917b5 35
Physicochemical characterization cascade of nanoadjuvant–antigen systems for improving vaccines, file e0feeaaa-3b0e-44d2-e053-6605fe0a8db0 29
B cell response after SARS-CoV-2 mRNA vaccination in people living with HIV, file 8813b76e-2fb3-4533-b729-93d6aa903340 23
Correlates of vaccine-induced protective immunity against Ebola virus disease, file e0feeaa7-df9e-44d2-e053-6605fe0a8db0 22
Determinants of antibody persistence across doses and continents after single-dose rVSV-ZEBOV vaccination for Ebola virus disease: an observational cohort study, file e0feeaab-70bb-44d2-e053-6605fe0a8db0 18
Ebola vaccine R&D: Filling the knowledge gaps, file e0feeaab-85b8-44d2-e053-6605fe0a8db0 17
Profiling the B cell immune response elicited by vaccination against the respiratory virus SARS-CoV-2, file cdbea7cb-101d-4a10-8520-cf993b601b6b 16
Monitoring Anti-PEG Antibodies Level upon Repeated Lipid Nanoparticle-Based COVID-19 Vaccine Administration, file f7d67566-4c9f-4325-9873-bebba438f92b 16
A dose-dependent plasma signature of the safety and immunogenicity of the rVSV-Ebola vaccine in Europe and Africa, file e0feeaab-a013-44d2-e053-6605fe0a8db0 12
Rapid dose-dependent Natural Killer (NK) cell modulation and cytokine responses following human rVSV-ZEBOV Ebolavirus vaccination, file e0feeaa8-b562-44d2-e053-6605fe0a8db0 9
The slower antibody response in myelofibrosis patients after two doses of MRNA sars-COV-2 vaccine calls for a third dose, file e930f3e7-c35d-4fb2-a5e2-34914c8dbdfc 8
Trajectory of Spike-Specific B Cells Elicited by Two Doses of BNT162b2 mRNA Vaccine, file d868aa3a-943e-461f-84cd-1ada9ae596f8 7
Using IFN-gamma release assay to confirm tuberculin skin test improves the screening of latent tuberculosis infection in Italian healthcare workers, file e0feeaa5-bfeb-44d2-e053-6605fe0a8db0 5
Ebola vaccine R&D: Filling the knowledge gaps, file e0feeaa5-7c27-44d2-e053-6605fe0a8db0 4
Stimulation of human monocytes with the gram-positive vaccine vector Streptococcus gordonii, file e0feeaa5-cd08-44d2-e053-6605fe0a8db0 4
Determinants of antibody persistence across doses and continents after single-dose rVSV-ZEBOV vaccination for Ebola virus disease: an observational cohort study, file e0feeaa7-de08-44d2-e053-6605fe0a8db0 3
Valutazione della risposta al test IGRA in pazienti pediatrici contatto di TBC o con sospetto clinico di infezione attiva, file e0feeaa6-f038-44d2-e053-6605fe0a8db0 2
Transcriptomic signatures induced by the Ebola virus vaccine rVSVΔG-ZEBOV-GP in adult cohorts in Europe, Africa, and North America: a molecular biomarker study, file e0feeaab-a24f-44d2-e053-6605fe0a8db0 2
Harmonization and qualification of intracellular cytokine staining to measure influenza-specific CD4+ T cell immunity within the FLUCOP consortium, file 88a1cca4-b633-468e-a984-70905543dc53 1
Does Nirmatrelvir/Ritonavir Influence the Immune Response against SARS-CoV-2, Independently from Rebound?, file d78a550b-0c6c-45ab-9b29-e8566e1ec8a9 1
Primary activation of antigen-specific naive CD4+ and CD8+ T cells following intranasal vaccination with recombinant bacteria, file e0feeaa4-d1ba-44d2-e053-6605fe0a8db0 1
In vivo mucosal delivery of bioactive human interleukin 1 recepor antagonist produced by Streptococcus gordonii, file e0feeaa4-dff9-44d2-e053-6605fe0a8db0 1
ADITEC: joining forces for next-generation vaccines, file e0feeaa4-f11e-44d2-e053-6605fe0a8db0 1
null, file e0feeaa5-6f39-44d2-e053-6605fe0a8db0 1
Nuovi approci diagnostici nelle infezioni pneumococciche: possibile ruolo della Real-time PCR e dei biomarcatori, file e0feeaa6-eac1-44d2-e053-6605fe0a8db0 1
Totale 2.520
Categoria #
all - tutte 12.453
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 12.453


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201986 0 0 0 0 0 0 0 0 0 20 36 30
2019/2020318 21 14 14 41 28 27 39 31 43 23 17 20
2020/2021502 14 21 15 18 18 26 40 40 49 95 69 97
2021/2022602 56 71 21 16 59 30 38 23 25 33 173 57
2022/2023558 21 12 143 78 52 89 29 22 17 35 31 29
2023/2024422 11 27 34 43 31 72 108 52 8 36 0 0
Totale 2.520